$SSKN
STRATA Skin Sciences, Inc.

2020 Q4 Form 10-Q Financial Statement

#000105151420000057 Filed on November 10, 2020

View on sec.gov

Income Statement

Concept 2020 Q4 2020 Q3 2019 Q3
Revenue $6.720M $5.613M $7.480M
YoY Change -24.49% -24.96% -3.22%
Cost Of Revenue $2.180M $2.383M $2.855M
YoY Change -21.3% -16.53% -7.87%
Gross Profit $4.540M $3.230M $4.625M
YoY Change -25.94% -30.16% -0.11%
Gross Profit Margin 67.56% 57.54% 61.83%
Selling, General & Admin $4.570M $3.980M $5.105M
YoY Change -23.45% -22.04% 6.89%
% of Gross Profit 100.66% 123.22% 110.38%
Research & Development $320.0K $411.0K $249.0K
YoY Change 52.38% 65.06% 11.16%
% of Gross Profit 7.05% 12.72% 5.38%
Depreciation & Amortization $800.0K $454.0K $637.0K
YoY Change -24.53% -28.73% -25.06%
% of Gross Profit 17.62% 14.06% 13.77%
Operating Expenses $4.890M $4.391M $5.354M
YoY Change -21.0% -17.99% 7.08%
Operating Profit -$350.0K -$1.161M -$729.0K
YoY Change 483.33% 59.26% 97.03%
Interest Expense -$20.00K -$20.00K $153.0K
YoY Change -75.0% -113.07% -35.98%
% of Operating Profit
Other Income/Expense, Net -$21.00K -$153.0K
YoY Change -86.27% -51.89%
Pretax Income -$380.0K -$1.182M -$882.0K
YoY Change -30.91% 34.01% 28.2%
Income Tax $70.00K $72.00K -$22.00K
% Of Pretax Income
Net Earnings -$440.0K -$1.254M -$860.0K
YoY Change -15.38% 45.81% 41.45%
Net Earnings / Revenue -6.55% -22.34% -11.5%
Basic Earnings Per Share -$0.04 -$0.03
Diluted Earnings Per Share -$13.02K -$0.04 -$0.03
COMMON SHARES
Basic Shares Outstanding 33.77M 33.75M 32.90M
Diluted Shares Outstanding 33.75M 32.90M

Balance Sheet

Concept 2020 Q4 2020 Q3 2019 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $10.60M $11.06M $16.23M
YoY Change 30.38% -31.85% 2.14%
Cash & Equivalents $10.60M $11.06M $16.23M
Short-Term Investments
Other Short-Term Assets $7.840M $7.860M $530.0K
YoY Change -2.12% 1383.02% -20.9%
Inventory $3.444M $3.502M $3.586M
Prepaid Expenses
Receivables $2.944M $2.510M $3.645M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $24.83M $24.94M $23.98M
YoY Change 5.42% 3.97% 10.15%
LONG-TERM ASSETS
Property, Plant & Equipment $5.529M $5.258M $4.568M
YoY Change 2.98% 15.11% -19.83%
Goodwill $8.803M $8.803M $8.803M
YoY Change 0.0% 0.0% 0.0%
Intangibles $6.345M $6.697M $8.407M
YoY Change -20.24% -20.34% -17.72%
Long-Term Investments
YoY Change
Other Assets $282.0K $298.0K $363.0K
YoY Change -18.73% -17.91% 656.25%
Total Long-Term Assets $21.95M $22.13M $23.53M
YoY Change -7.74% -5.97% -4.98%
TOTAL ASSETS
Total Short-Term Assets $24.83M $24.94M $23.98M
Total Long-Term Assets $21.95M $22.13M $23.53M
Total Assets $46.78M $47.06M $47.52M
YoY Change -1.19% -0.95% 2.1%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $2.764M $3.488M $1.997M
YoY Change 47.02% 74.66% 20.08%
Accrued Expenses $4.690M $4.558M $4.937M
YoY Change -8.65% -7.68% 16.25%
Deferred Revenue $2.262M $1.864M $2.483M
YoY Change -20.13% -24.93% 32.29%
Short-Term Debt $7.280M $7.280M $0.00
YoY Change 0.0%
Long-Term Debt Due $1.478M $1.134M $2.524M
YoY Change -55.07%
Total Short-Term Liabilities $18.84M $18.68M $12.19M
YoY Change 8.05% 53.25% 28.14%
LONG-TERM LIABILITIES
Long-Term Debt $1.050M $1.394M $4.980M
YoY Change -72.01% -32.36%
Other Long-Term Liabilities $34.00K $52.00K $327.0K
YoY Change -80.9% -84.1% 21.56%
Total Long-Term Liabilities $1.084M $1.446M $5.307M
YoY Change 508.99% -72.75% -30.45%
TOTAL LIABILITIES
Total Short-Term Liabilities $18.84M $18.68M $12.19M
Total Long-Term Liabilities $1.084M $1.446M $5.307M
Total Liabilities $20.89M $21.14M $18.66M
YoY Change 11.75% 13.27% 8.82%
SHAREHOLDERS EQUITY
Retained Earnings -$219.0M -$218.5M -$214.0M
YoY Change 2.06% 2.09% 2.08%
Common Stock $34.00K $34.00K $33.00K
YoY Change 3.03% 3.03% 10.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $25.89M $25.93M $28.86M
YoY Change
Total Liabilities & Shareholders Equity $46.78M $47.06M $47.52M
YoY Change -1.19% -0.95% 2.1%

Cashflow Statement

Concept 2020 Q4 2020 Q3 2019 Q3
OPERATING ACTIVITIES
Net Income -$440.0K -$1.254M -$860.0K
YoY Change -15.38% 45.81% 41.45%
Depreciation, Depletion And Amortization $800.0K $454.0K $637.0K
YoY Change -24.53% -28.73% -25.06%
Cash From Operating Activities $350.0K $550.0K $710.0K
YoY Change -68.47% -22.54% -62.03%
INVESTING ACTIVITIES
Capital Expenditures -$710.0K -$720.0K -$430.0K
YoY Change -49.65% 67.44% 16.22%
Acquisitions
YoY Change
Other Investing Activities $0.00
YoY Change
Cash From Investing Activities -$710.0K -$720.0K -$430.0K
YoY Change -49.65% 67.44% 16.22%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 20.00K 0.000 0.000
YoY Change -106.67% -100.0%
NET CHANGE
Cash From Operating Activities 350.0K 550.0K 710.0K
Cash From Investing Activities -710.0K -720.0K -430.0K
Cash From Financing Activities 20.00K 0.000 0.000
Net Change In Cash -340.0K -170.0K 280.0K
YoY Change -43.33% -160.71% -80.69%
FREE CASH FLOW
Cash From Operating Activities $350.0K $550.0K $710.0K
Capital Expenditures -$710.0K -$720.0K -$430.0K
Free Cash Flow $1.060M $1.270M $1.140M
YoY Change -57.94% 11.4% -49.11%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2019Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
5134000
CY2019Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
15962000
CY2020Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
17404000
CY2020Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
244423000
CY2019Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
243180000
CY2019Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
323000
CY2019Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
1880000
CY2020Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
3488000
CY2020Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
2510000
CY2019Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
4386000
CY2020Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
4558000
CY2019Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
257000
CY2020Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
403000
CY2019Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
303000
CY2020Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
410000
CY2020Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
430000
CY2019Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
184000
CY2020Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
249000
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
0
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
64000
CY2019Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
453000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1258000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1358000
CY2020Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
353000
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
43000
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
384000
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
0
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
6078554
CY2019Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
5227130
CY2020Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
5177269
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
5588598
CY2019Q4 us-gaap Assets
Assets
47343000
CY2020Q3 us-gaap Assets
Assets
47064000
CY2019Q4 us-gaap Assets Current
AssetsCurrent
23555000
CY2020Q3 us-gaap Assets Current
AssetsCurrent
24936000
CY2020Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
11063000
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
8129000
CY2019Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
16228000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
2831000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-259000
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
15629000
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
16487000
CY2020Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
18460000
CY2019Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
16228000
CY2020Q3 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
3.75
CY2020Q3 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
149901
CY2020Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2019Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2020Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2019Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2020Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
33754909
CY2019Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
32932273
CY2019Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
150000000
CY2020Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
150000000
CY2019Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
32932273
CY2020Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
33754909
CY2020Q3 us-gaap Common Stock Value
CommonStockValue
34000
CY2019Q4 us-gaap Common Stock Value
CommonStockValue
33000
CY2019Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
2832000
CY2020Q3 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
1864000
CY2020Q3 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
52000
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
162000
CY2019Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.03
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.10
CY2020Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.04
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.12
CY2020Q3 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
23000
us-gaap Cost Of Revenue
CostOfRevenue
6780000
us-gaap Cost Of Revenue
CostOfRevenue
8544000
CY2019Q3 us-gaap Cost Of Revenue
CostOfRevenue
2855000
CY2020Q3 us-gaap Cost Of Revenue
CostOfRevenue
2383000
CY2019Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
0
CY2020Q3 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
207000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-111000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
207000
CY2020Q3 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
454000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
2079000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1535000
CY2019Q3 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
637000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
2793000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
3437000
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.12
CY2019Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.03
CY2020Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.04
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.10
CY2020Q3 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
1607000
CY2019Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
1193000
CY2020Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
780000
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-968000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
207000
CY2020Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
352000
CY2020Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
1410000
CY2020Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
6697000
CY2020Q3 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
16100000
CY2020Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
1410000
CY2020Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
1410000
CY2020Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
9403000
CY2020Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
1410000
CY2020Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
705000
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-23000
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-29000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
5921000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
7398000
CY2019Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2218000
CY2020Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1929000
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
CY2020Q3 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
CY2019Q4 us-gaap Goodwill
Goodwill
8803000
CY2020Q3 us-gaap Goodwill
Goodwill
8803000
us-gaap Gross Profit
GrossProfit
14144000
CY2020Q3 us-gaap Gross Profit
GrossProfit
3230000
CY2019Q3 us-gaap Gross Profit
GrossProfit
4625000
us-gaap Gross Profit
GrossProfit
9593000
us-gaap Income Tax Examination Estimate Of Possible Loss
IncomeTaxExaminationEstimateOfPossibleLoss
801000
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-3762000
CY2019Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-882000
CY2020Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-1182000
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-3386000
CY2020Q3 us-gaap Income Tax Examination Interest Accrued
IncomeTaxExaminationInterestAccrued
171000
CY2020Q3 us-gaap Income Tax Examination Liability Refund Adjustment From Settlement With Taxing Authority
IncomeTaxExaminationLiabilityRefundAdjustmentFromSettlementWithTaxingAuthority
720000
CY2019Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-22000
CY2020Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
72000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-111000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
233000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
1608000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-1811000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
261000
us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
-576000
us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
437000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
792000
CY2019Q4 us-gaap Inventory Work In Process And Raw Materials
InventoryWorkInProcessAndRawMaterials
2651000
CY2019Q4 us-gaap Inventory Net
InventoryNet
3027000
CY2020Q3 us-gaap Inventory Net
InventoryNet
3502000
CY2020Q3 us-gaap Lessee Operating Lease Term Of Contract
LesseeOperatingLeaseTermOfContract
P36M
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
475000
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-61000
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-126000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-76000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-98000
CY2020Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
6697000
CY2019Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
7955000
CY2020Q3 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-21000
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-38000
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-433000
CY2019Q3 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-153000
us-gaap Interest Paid Net
InterestPaidNet
604000
us-gaap Interest Paid Net
InterestPaidNet
157000
CY2020Q3 us-gaap Inventory Finished Goods
InventoryFinishedGoods
431000
CY2019Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
376000
CY2020Q3 us-gaap Inventory Work In Process And Raw Materials
InventoryWorkInProcessAndRawMaterials
3071000
CY2020Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
242000
CY2020Q3 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
205000
CY2020Q3 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
115000
CY2020Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
186000
CY2020Q3 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
1370000
CY2020Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
371000
CY2020Q3 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
456000
CY2019Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
47343000
CY2020Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
47064000
CY2019Q4 us-gaap Liabilities
Liabilities
18690000
CY2020Q3 us-gaap Liabilities
Liabilities
21137000
CY2019Q4 us-gaap Liabilities Current
LiabilitiesCurrent
17434000
CY2020Q3 us-gaap Liabilities Current
LiabilitiesCurrent
18680000
CY2020Q3 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
1394000
CY2019Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
0
CY2019Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
0
CY2020Q3 us-gaap Long Term Debt Current
LongTermDebtCurrent
1134000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
1116000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
1750000
CY2019Q3 us-gaap Net Income Loss
NetIncomeLoss
-860000
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
-1254000
us-gaap Net Income Loss
NetIncomeLoss
-3275000
us-gaap Net Income Loss
NetIncomeLoss
-3969000
CY2020Q3 us-gaap Long Term Debt
LongTermDebt
2528000
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
-1035000
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
-1680000
CY2019Q2 us-gaap Net Income Loss
NetIncomeLoss
-1082000
CY2019Q1 us-gaap Net Income Loss
NetIncomeLoss
-1333000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1375000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1447000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
0
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
2528000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-38000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-433000
CY2020Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-21000
CY2019Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-153000
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
2
us-gaap Operating Lease Payments
OperatingLeasePayments
314000
us-gaap Operating Lease Payments
OperatingLeasePayments
320000
CY2020Q3 us-gaap Operating Lease Payments
OperatingLeasePayments
113000
CY2019Q3 us-gaap Operating Lease Payments
OperatingLeasePayments
110000
CY2020Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
1165000
CY2020Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
804000
CY2019Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
1078000
CY2020Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
361000
CY2019Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
313000
CY2020Q3 us-gaap Operating Expenses
OperatingExpenses
4391000
us-gaap Operating Expenses
OperatingExpenses
17097000
us-gaap Operating Expenses
OperatingExpenses
13317000
CY2019Q3 us-gaap Operating Expenses
OperatingExpenses
5354000
us-gaap Operating Lease Cost
OperatingLeaseCost
335000
CY2019Q3 us-gaap Operating Lease Cost
OperatingLeaseCost
108000
CY2020Q3 us-gaap Operating Lease Cost
OperatingLeaseCost
112000
us-gaap Operating Lease Cost
OperatingLeaseCost
336000
CY2020Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
1072000
CY2019Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
1314000
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
242000
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
240000
CY2020Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P3Y4M24D
us-gaap Operating Income Loss
OperatingIncomeLoss
-3724000
CY2019Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-729000
us-gaap Operating Income Loss
OperatingIncomeLoss
-2953000
CY2020Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2019Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
2103
CY2020Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-1161000
CY2020Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
298000
CY2019Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
347000
CY2020Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
52000
CY2019Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
178000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
17000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
5000
CY2019Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
2103
CY2020Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2020Q3 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2019Q4 us-gaap Preferred Stock Value
PreferredStockValue
1000
CY2020Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.10
CY2019Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.10
CY2019Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2020Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2020Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
464000
CY2019Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
513000
us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<div style="font-family: 'Times New Roman'; font-size: 10pt;"><div style="text-align: justify; font-style: italic; font-weight: bold;">Reclassifications</div><div style="text-align: justify;">Certain reclassifications from the prior year presentation have been made to conform to the current year presentation. These reclassifications did not have a material impact on the Company&#8217;s equity, results of operations, or cash flows.</div></div>
us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
2528000
us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
0
CY2020Q3 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
107000
CY2019Q4 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
170000
CY2019Q3 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
179000
CY2020Q3 us-gaap Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
41000
CY2019Q3 us-gaap Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
61000
us-gaap Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
143000
us-gaap Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
151000
CY2019Q2 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
291000
CY2020Q2 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
139000
CY2018Q4 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
238000
CY2019Q4 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
232000
CY2019Q3 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
256000
CY2020Q3 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
135000
us-gaap Product Warranty Accrual Period Increase Decrease
ProductWarrantyAccrualPeriodIncreaseDecrease
169000
CY2019Q3 us-gaap Product Warranty Accrual Period Increase Decrease
ProductWarrantyAccrualPeriodIncreaseDecrease
26000
us-gaap Product Warranty Accrual Period Increase Decrease
ProductWarrantyAccrualPeriodIncreaseDecrease
46000
CY2020Q3 us-gaap Product Warranty Accrual Period Increase Decrease
ProductWarrantyAccrualPeriodIncreaseDecrease
37000
CY2019Q3 us-gaap Product Warranty Accrual Noncurrent
ProductWarrantyAccrualNoncurrent
77000
CY2020Q3 us-gaap Product Warranty Accrual Noncurrent
ProductWarrantyAccrualNoncurrent
28000
CY2019Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
2887000
CY2020Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
2051000
us-gaap Share Based Compensation
ShareBasedCompensation
883000
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
9000
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
65000
us-gaap Share Based Compensation
ShareBasedCompensation
1243000
CY2019Q3 us-gaap Restricted Cash Current
RestrictedCashCurrent
0
CY2020Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-218530000
CY2019Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-214561000
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
6446000
CY2020Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
22662000
CY2019Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
21331000
CY2020Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
5258000
CY2019Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
5369000
CY2020Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
411000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
788000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
950000
CY2019Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
249000
CY2019Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
7500000
CY2020Q3 us-gaap Restricted Cash Current
RestrictedCashCurrent
7397000
CY2019Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
7480000
CY2020Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
5613000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
16373000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
22688000
CY2020Q3 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
162000
CY2020Q3 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
139000
CY2020Q3 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P1Y
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P0Y10M28D
CY2019Q4 us-gaap Sales And Excise Tax Payable Current
SalesAndExciseTaxPayableCurrent
3193000
CY2020Q3 us-gaap Sales And Excise Tax Payable Current
SalesAndExciseTaxPayableCurrent
3094000
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
8911000
CY2020Q3 us-gaap Share Based Compensation
ShareBasedCompensation
403000
CY2019Q3 us-gaap Share Based Compensation
ShareBasedCompensation
257000
CY2019Q4 us-gaap Short Term Bank Loans And Notes Payable
ShortTermBankLoansAndNotesPayable
7275000
CY2020Q3 us-gaap Short Term Bank Loans And Notes Payable
ShortTermBankLoansAndNotesPayable
7275000
CY2019Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
0
CY2019Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
0
CY2020Q2 us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
0
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
25927000
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
28653000
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
31248000
CY2019Q1 us-gaap Stockholders Equity
StockholdersEquity
30238000
CY2019Q2 us-gaap Stockholders Equity
StockholdersEquity
29459000
CY2019Q3 us-gaap Stockholders Equity
StockholdersEquity
28856000
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
26778000
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
28048000
us-gaap Use Of Estimates
UseOfEstimates
<div style="font-family: 'Times New Roman'; font-size: 10pt;"><div style="text-align: justify; font-style: italic; font-weight: bold;">Use of Estimates</div><div style="text-align: justify;">The preparation of the condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect amounts reported of assets and liabilities at the date of the financial statements and the reported amount of revenues and expenses during the reporting periods. Actual results could differ from those estimates and be based on events different from those assumptions. As of September 30, 2020, the more significant estimates include (1) revenue recognition, in regard to deferred revenues and the contract term and valuation allowances of accounts receivable, (2) the inputs used in the impairment analyses of goodwill, (3) the estimated useful lives of intangible assets and property and equipment, (4) the inputs used in determining the fair value of equity-based awards, (5) the valuation allowance related to deferred tax assets, (6) the inventory reserves, (7) state sales and use tax accruals and (8) warranty claims.</div><div>&#160;</div><div style="text-align: justify;">Additionally, the full impact of the COVID-19 outbreak is unknown and cannot be reasonably estimated. However, management has made appropriate accounting estimates on certain accounting matters, which include the allowance for doubtful accounts, inventory valuation, carrying value of the goodwill and other long-lived assets, based on the facts and circumstances available as of the reporting date. The Company&#8217;s future assessment of the magnitude and duration of the COVID-19 outbreak, as well as other factors, could result in material impacts to the Company&#8217;s financial statements in future reporting periods.</div></div>
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
31663355
CY2020Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
33754909
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
33551070
CY2019Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
32903287
CY2019Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
32903287
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
33551070
CY2020Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
33754909
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
31663355
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Period End Date
DocumentPeriodEndDate
2020-09-30
dei Entity Address State Or Province
EntityAddressStateOrProvince
PA
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Registrant Name
EntityRegistrantName
STRATA Skin Sciences, Inc.
dei Entity Central Index Key
EntityCentralIndexKey
0001051514
sskn Earnings Per Share Basic And Diluted Preferred Share
EarningsPerShareBasicAndDilutedPreferredShare
-43.73
CY2020Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
33769909
CY2019Q3 sskn Percentage Of Gross Profit
PercentageOfGrossProfit
0.6180
sskn Percentage Of Gross Profit
PercentageOfGrossProfit
0.5860
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2020
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Document Type
DocumentType
10-Q
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Shell Company
EntityShellCompany
false
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Small Business
EntitySmallBusiness
true
sskn Increase Decrease In Operating Lease Liabilities
IncreaseDecreaseInOperatingLeaseLiabilities
-226000
sskn Increase Decrease In Operating Lease Liabilities
IncreaseDecreaseInOperatingLeaseLiabilities
-219000
sskn Payment For Lasers Placed In Service Net
PaymentForLasersPlacedInServiceNet
1370000
sskn Payment For Lasers Placed In Service Net
PaymentForLasersPlacedInServiceNet
1430000
sskn Increase Decrease Of Lease Liabilities Arising From Obtaining Right Of Use Assets
IncreaseDecreaseOfLeaseLiabilitiesArisingFromObtainingRightOfUseAssets
1632000
sskn Increase Decrease Of Lease Liabilities Arising From Obtaining Right Of Use Assets
IncreaseDecreaseOfLeaseLiabilitiesArisingFromObtainingRightOfUseAssets
0
CY2019Q3 sskn Earnings Per Share Basic And Diluted Preferred Share
EarningsPerShareBasicAndDilutedPreferredShare
-9.58
sskn Earnings Per Share Basic And Diluted Preferred Share
EarningsPerShareBasicAndDilutedPreferredShare
-36.14
CY2020Q3 sskn Earnings Per Share Basic And Diluted Preferred Share
EarningsPerShareBasicAndDilutedPreferredShare
0
CY2020Q3 sskn Weighted Average Number Of Share Outstanding Basic And Diluted Preferred Stock
WeightedAverageNumberOfShareOutstandingBasicAndDilutedPreferredStock
0
CY2019Q3 sskn Weighted Average Number Of Share Outstanding Basic And Diluted Preferred Stock
WeightedAverageNumberOfShareOutstandingBasicAndDilutedPreferredStock
2103
sskn Weighted Average Number Of Share Outstanding Basic And Diluted Preferred Stock
WeightedAverageNumberOfShareOutstandingBasicAndDilutedPreferredStock
491
sskn Weighted Average Number Of Share Outstanding Basic And Diluted Preferred Stock
WeightedAverageNumberOfShareOutstandingBasicAndDilutedPreferredStock
5412
CY2020Q3 sskn Contract With Customer Liability Current Advance Consideration
ContractWithCustomerLiabilityCurrentAdvanceConsideration
139000
sskn Co Pay Reimbursements Recorded As Reduction Of Revenue
CoPayReimbursementsRecordedAsReductionOfRevenue
-545000
CY2019Q3 sskn Co Pay Reimbursements Recorded As Reduction Of Revenue
CoPayReimbursementsRecordedAsReductionOfRevenue
-213000
CY2020Q3 sskn Co Pay Reimbursements Recorded As Reduction Of Revenue
CoPayReimbursementsRecordedAsReductionOfRevenue
-160000
sskn Co Pay Reimbursements Recorded As Reduction Of Revenue
CoPayReimbursementsRecordedAsReductionOfRevenue
-414000
CY2019Q1 sskn Conversion Of Convertible Preferred Stock Amount
ConversionOfConvertiblePreferredStockAmount
0
CY2020Q1 sskn Conversion Of Convertible Preferred Stock Amount
ConversionOfConvertiblePreferredStockAmount
0
CY2019Q2 sskn Conversion Of Convertible Preferred Stock Amount
ConversionOfConvertiblePreferredStockAmount
0
sskn Percentage Of Gross Profit
PercentageOfGrossProfit
0.6230
CY2020Q3 sskn Percentage Of Gross Profit
PercentageOfGrossProfit
0.5750
CY2020Q3 sskn Accrued Professional Fees Other Accrued Liabilities
AccruedProfessionalFeesOtherAccruedLiabilities
577000
CY2019Q4 sskn Accrued Professional Fees Other Accrued Liabilities
AccruedProfessionalFeesOtherAccruedLiabilities
578000
sskn Operating Lease Incremental Borrowing Rate Percent
OperatingLeaseIncrementalBorrowingRatePercent
0.0976
sskn Class Of Warrant Or Right Expired
ClassOfWarrantOrRightExpired
600000
CY2020Q3 sskn Class Of Warrant Or Right Expired
ClassOfWarrantOrRightExpired
0
CY2020Q3 sskn Delayed Payment To Vendors
DelayedPaymentToVendors
1100000

Files In Submission

Name View Source Status
0001051514-20-000057-index-headers.html Edgar Link pending
0001051514-20-000057-index.html Edgar Link pending
0001051514-20-000057.txt Edgar Link pending
0001051514-20-000057-xbrl.zip Edgar Link pending
ex_31-1.htm Edgar Link pending
ex_31-2.htm Edgar Link pending
ex_32-1.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
form_10-q.htm Edgar Link pending
image0.jpg Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
sskn-20200930.xml Edgar Link completed
sskn-20200930.xsd Edgar Link pending
sskn-20200930_cal.xml Edgar Link unprocessable
sskn-20200930_def.xml Edgar Link unprocessable
sskn-20200930_lab.xml Edgar Link unprocessable
sskn-20200930_pre.xml Edgar Link unprocessable